Table 1 Baseline characteristics by atrial fibrillation at dialysis initiation.
From: Atrial Fibrillation Characteristics in Patients on Haemodialysis vs. Peritoneal Dialysis
Group | All (N = 1,130) | No AF (n = 826) | AF Ever (n = 304) | P-value |
|---|---|---|---|---|
Age (years) | 63.8 ± 14.7 | 61.6 ± 15.3 | 70 ± 10.6 | <0.001 |
Male (n, %) | 661 (58.5%) | 479 (58.0%) | 182 (59.9%) | 0.57 |
Haemodialysis (n, %) | 1021 (90.4%) | 738 (89.3%) | 283 (93.1%) | 0.06 |
Peritoneal dialysis (n, %) | 109 (9.6%) | 88 (10.7%) | 21 (6.9%) | 0.06 |
AF prior to dialysis (n, %) | 133 (11.8%) | — | 133 (43.8%) | — |
Diabetes mellitus (n, %) | 731 (64.7%) | 505 (61.1%) | 226 (74.3%) | <0.001 |
Heart failure (n, %) | 275 (24.3%) | 151 (18.3%) | 124 (40.8%) | <0.001 |
Hypertension (n, %) | 884 (78.2%) | 629 (76.2%) | 255 (83.9%) | 0.01 |
Coronary artery disease (n, %) | 441 (39.0%) | 276 (33.4%) | 165 (54.3%) | <0.001 |
Myocardial infarction (n, %) | 230 (20.4%) | 148 (17.9%) | 82 (27.0%) | 0.001 |
Pulmonary hypertension (n, %) | 51 (4.5%) | 21 (2.5%) | 30 (9.9%) | <0.001 |
Dyslipidaemia (n, %) | 901 (79.7%) | 637 (77.1%) | 264 (86.8%) | <0.001 |
Peripheral vascular disease (n, %) | 133 (11.8%) | 87 (10.5%) | 46 (15.1%) | 0.03 |
Intracranial haemorrhage (n, %) | 20 (1.8%) | 14 (1.7%) | 6 (2.0%) | 0.75 |
Cerebrovascular event (n, %) | 119 (10.5%) | 73 (8.8%) | 46 (15.1%) | 0.002 |
CHA2DS2-VASc score (median, interquartile range) | 3 (2,5) | 3 (2,4) | 4 (3,5) | <0.001 |
Chronic obstructive pulmonary disease (n, %) | 47 (4.2%) | 29 (3.5%) | 18 (5.9%) | 0.07 |
Smoking (ever, n, %) | 465 (41.2%) | 347 (42.0%) | 118 (38.8%) | 0.33 |
Hyperthyroidism (n, %) | 25 (2.2%) | 20 (2.4%) | 5 (1.6%) | 0.43 |
Albumin (g/dl, average) | 3.4 ± 0.6 | 3.5 ± 0.6 | 3.3 ± 0.6 | 0.004 |
Haemoglobin (g/dl, average) | 10.3 ± 1.7 | 10.3 ± 1.7 | 10.3 ± 1.6 | 0.88 |
Mean follow-up time (months) | 39.7 ± 32.3 | 40.1 ± 33 | 38.5 ± 30.5 | 0.46 |
Transplant after dialysis (n, %) | 89 (7.9%) | 78 (9.4%) | 11 (3.6%) | 0.001 |
